GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » 10-Year ROIIC %

Malaysian Genomics Resource Centre Bhd (XKLS:0155) 10-Year ROIIC % : -684.98% (As of Jun. 2021)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % for the quarter that ended in Jun. 2021 was -684.98%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % or its related term are showing as below:

XKLS:0155's 10-Year ROIIC % is ranked worse than
96.63% of 208 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.125 vs XKLS:0155: -684.98

Malaysian Genomics Resource Centre Bhd 10-Year ROIIC % Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd 10-Year ROIIC % Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -94.03 - -684.98

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC %

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % falls into.



Malaysian Genomics Resource Centre Bhd 10-Year ROIIC % Calculation

Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % for the quarter that ended in Jun. 2021 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -4.335 (Jun. 2021) - 2.1312294 (Jun. 2011) )/( 11.252 (Jun. 2021) - 10.308 (Jun. 2011) )
=-6.4662294/0.944
=-684.98%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Malaysian Genomics Resource Centre Bhd 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines